Montana Cancer Consortium (EIN 810503295) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1995

Legal Domicile

Principal Officer

John Schallenkamp MD

Phone

4069696060

Tax Period

2024-06-01 to 2025-05-31

Montana Cancer Consortium, founded in 1995, is a small nonprofit in the Diseases & Disorders sector that reported $997K in total revenue in fiscal year 2024. Revenue fell 22% from the prior year — a significant decline worth monitoring. Expenses of $873K left a modest 13% surplus.

Mission

Promote and supervise cancer research.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $983,678

Program Service Revenue $13,750

Investment Income $0

Other Revenue $0

TOTAL REVENUE $997,428

Expense Breakdown

Grants Paid $0

Salaries & Benefits $424,216

Fundraising Expenses $0

Program Expenses $673,053

Other Expenses $448,296

TOTAL EXPENSES $872,512

Year-over-Year Comparison

	2024	2023	Change
Revenue	$997,428	$1,281,172	-0.2%
Expenses	$872,512	$914,706	0.0%
Net Income	$124,916	$366,466	-0.7%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$112,760

Total Directors

$112,760

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
John Schallenkamp MD	President	4.00	Officer Director	$0	$0	$0
Jeffrey Allen MD	Vice-President	1.00	Officer Director	$0	$0	$0
Michelle Proper MD	Director	1.00	Director	$0	$0	$0
Christopher Goulet MD	Director	1.00	Director	$0	$0	$0
James Hueftle MD	Director	1.00	Director	$0	$0	$0
Justin Thomas MD	Director	1.00	Director	$0	$0	$0
Amanda Dinsdale	Secretary/Treasurer	40.00	Officer Director	$94,806	$17,954	$112,760

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$997,428	$872,512	$847,887	$124,916
2024	$1,281,172	$914,706	$722,971	$366,466
2023	$606,614	$857,790	$361,432	$-251,176
2022	$897,407	$859,211	$606,905	$38,196
2021	$1,142,804	$1,144,656	$569,925	$-1,852
2020	$1,023,410	$891,480	$572,047	$131,930
2019	$962,008	$978,290	$439,752	$-16,282
2018	$868,519	$905,128	$455,732	$-36,609

Montana Cancer Consortium